Cacabelos, R.; Fernández-Novoa, L.; Martínez-Bouza, R.; McKay, A.; Carril, J.C.; Lombardi, V.; Corzo, L.; Carrera, I.; Tellado, I.; Nebril, L.;
et al. Future Trends in the Pharmacogenomics of Brain Disorders and Dementia: Influence of APOE and CYP2D6 Variants. Pharmaceuticals 2010, 3, 3040-3100.
https://doi.org/10.3390/ph3103040
AMA Style
Cacabelos R, Fernández-Novoa L, Martínez-Bouza R, McKay A, Carril JC, Lombardi V, Corzo L, Carrera I, Tellado I, Nebril L,
et al. Future Trends in the Pharmacogenomics of Brain Disorders and Dementia: Influence of APOE and CYP2D6 Variants. Pharmaceuticals. 2010; 3(10):3040-3100.
https://doi.org/10.3390/ph3103040
Chicago/Turabian Style
Cacabelos, Ramón, Lucía Fernández-Novoa, Rocío Martínez-Bouza, Adam McKay, Juan C. Carril, Valter Lombardi, Lola Corzo, Iván Carrera, Iván Tellado, Laura Nebril,
and et al. 2010. "Future Trends in the Pharmacogenomics of Brain Disorders and Dementia: Influence of APOE and CYP2D6 Variants" Pharmaceuticals 3, no. 10: 3040-3100.
https://doi.org/10.3390/ph3103040
APA Style
Cacabelos, R., Fernández-Novoa, L., Martínez-Bouza, R., McKay, A., Carril, J. C., Lombardi, V., Corzo, L., Carrera, I., Tellado, I., Nebril, L., Alcaraz, M., Rodríguez, S., Casas, Á., Couceiro, V., & Álvarez, A.
(2010). Future Trends in the Pharmacogenomics of Brain Disorders and Dementia: Influence of APOE and CYP2D6 Variants. Pharmaceuticals, 3(10), 3040-3100.
https://doi.org/10.3390/ph3103040
